Literature DB >> 19327730

Notch signaling: where pancreatic cancer and differentiation meet?

Jean-Paul De La O, L Charles Murtaugh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19327730     DOI： 10.1053/j.gastro.2009.03.022

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  6 in total

1.  Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft models.

Authors:  Georg Feldmann; Anjali Mishra; Savita Bisht; Collins Karikari; Ignacio Garrido-Laguna; Zeshaan Rasheed; Niki A Ottenhof; Tikva Dadon; Hector Alvarez; Volker Fendrich; N V Rajeshkumar; William Matsui; Peter Brossart; Manuel Hidalgo; Rajat Bannerji; Anirban Maitra; Barry D Nelkin
Journal:  Cancer Biol Ther       Date:  2011-10-01       Impact factor: 4.742

Review 2.  Targeting Notch signaling pathway to overcome drug resistance for cancer therapy.

Authors:  Zhiwei Wang; Yiwei Li; Aamir Ahmad; Asfar S Azmi; Sanjeev Banerjee; Dejuan Kong; Fazlul H Sarkar
Journal:  Biochim Biophys Acta       Date:  2010-06-22

3.  KRAS Mouse Models: Modeling Cancer Harboring KRAS Mutations.

Authors:  Rónán C O'Hagan; Joerg Heyer
Journal:  Genes Cancer       Date:  2011-03

4.  Stress-Activated NRF2-MDM2 Cascade Controls Neoplastic Progression in Pancreas.

Authors:  Jelena Todoric; Laura Antonucci; Giuseppe Di Caro; Ning Li; Xuefeng Wu; Nikki K Lytle; Debanjan Dhar; Sourav Banerjee; Johan B Fagman; Cecille D Browne; Atsushi Umemura; Mark A Valasek; Hannes Kessler; David Tarin; Michael Goggins; Tannishtha Reya; Maria Diaz-Meco; Jorge Moscat; Michael Karin
Journal:  Cancer Cell       Date:  2017-11-16       Impact factor: 31.743

5.  Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells.

Authors:  Dara Nalls; Su-Ni Tang; Marianna Rodova; Rakesh K Srivastava; Sharmila Shankar
Journal:  PLoS One       Date:  2011-08-31       Impact factor: 3.240

6.  Activated K-ras and INK4a/Arf deficiency cooperate during the development of pancreatic cancer by activation of Notch and NF-κB signaling pathways.

Authors:  Zhiwei Wang; Sanjeev Banerjee; Aamir Ahmad; Yiwei Li; Asfar S Azmi; Jason R Gunn; Dejuan Kong; Bin Bao; Shadan Ali; Jiankun Gao; Ramzi M Mohammad; Lucio Miele; Murray Korc; Fazlul H Sarkar
Journal:  PLoS One       Date:  2011-06-03       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.